Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
356.2500 -2.70 (-0.75%)
NSE Sep 25, 2025 13:26 PM
Volume: 823.8K
High vol. this week

logo
Biocon Ltd.
27 Jul 2015
356.25
-0.75%
Phillip Capital
to deliver >20% earning CAGR over FY1517 led by (1) commercialisation of its Malaysia facility from Q4FY16, (2) resumption of Fidaxomicin supply contract with Merck, (3) commercial launch of Glargin (launched in Mexico and Columbia, approved in 18 other...
Number of FII/FPI investors increased from 305 to 333 in Jun 2025 qtr.
More from Biocon Ltd.
Recommended